Understanding how social factors affect HIV treatment adherence in African American adults
Examining Social Determinants of Antiretroviral Adherence Trajectories among African American Adults with HIV
This study looks at how things like community support and personal strength affect how well African American adults with HIV stick to their treatment, aiming to find ways to help them manage their health better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10932129 on NIH RePORTER |
What this research studies
This research investigates the social determinants that influence how well African American adults with HIV adhere to their antiretroviral therapy. It focuses on the unique challenges faced by this population, particularly those with low community cohesion, and examines the role of psychosocial factors such as resilience and social support. By utilizing a combination of qualitative and quantitative methods, the study aims to identify barriers and facilitators to effective HIV care and treatment adherence. The findings could help tailor interventions to improve health outcomes for this underserved group.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American adults aged 21 and older who are living with HIV and may experience challenges with medication adherence.
Not a fit: Patients who are not African American or those who do not have HIV may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for enhancing medication adherence among African American adults with HIV, ultimately improving their health outcomes.
How similar studies have performed: Previous research has shown that addressing psychosocial factors can significantly improve health outcomes in similar populations, indicating a promising approach.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Serrano, Vanessa Bianca — University of California, San Diego
- Study coordinator: Serrano, Vanessa Bianca
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.